CDER Reorganization Will Create Center-Level Associate Director For Safety
This article was originally published in The Pink Sheet Daily
Executive Summary
Proposed realignment also will include a new office to serve as a nexus for FDA's Critical Path initiatives.
You may also be interested in...
CDER Reorganization Takes Effect, With Renamed Offices
Safety functions and Critical Path activities are the focus of new CDER offices.
CDER Reorganization Takes Effect, With Renamed Offices
Safety functions and Critical Path activities are the focus of new CDER offices.
Drug Safety Bulletin Being Considered By FDA
The effort would be overseen by new Associate Center Director for Safety Policy & Communication Paul Seligman.